Interview with Chief Editor of Nature Cancer

Mar 03, 2020

Posted by Springer Nature

Cancer – a global health problem and the second leading cause of death worldwide today. The word itself has the ability of sending shivers up and down the spine. A devastating disease that touches the lives of many, from those that have the disease to those who witness first-hand the suffering it causes their loved ones. Over the decades due to the rise in new cancer diagnoses, cancer research has magnified exponentially. Researchers are eager to make headway on tackling this disease and all of its facets head on. A cure for cancer is the aim, but difficult to fulfil, as cancer itself is complex — a group of many diseases, where genetic, environmental and behavioural factors all have a role to play in its diagnosis. 

Read our interview with the Chief Editor of the soon to launch Nature Cancer, Alexia-Ileana Zaromytidou. Alexia discusses cancer and why it is a field very much close to her heart. Carry on reading to find out more about Alexia, what Nature Cancer plans to offer the cancer research community and Alexia’s thoughts on some of the scientific issues surrounding cancer at the moment.

Nature Cancer is one of the latest journal titles published by Springer Nature. View the full interview here.

Springer Nature is a Purchasing Consortium Member – members of MassBio with under 99 R&D staff members receive exclusive discounts, click here if you are interested in having unlimited access to research journals or ebooks from Springer Nature (or feel free to contact Caitlin Cricco at 

See all Member News